CAS 149845-06-7|Saquinavir mesylate

Introduction：Basic information about CAS 149845-06-7|Saquinavir mesylate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.

Table of Contents

1. Names
2. Saquinavir mesylate BiologicalActivity
3. Chemical & Physical Properties
4. Safety Information
5. Articles27
6. Synonyms

Common Name	Saquinavir mesylate
CAS Number	149845-06-7	Molecular Weight	766.946
Density	/	Boiling Point	1015ºC at 760 mmHg
Molecular Formula	C₃₉H₅₄N₆O₈S	Melting Point	/
MSDS	ChineseUSA	Flash Point	567.7ºC

Names

Name	Saquinavir Mesylate
Synonym	More Synonyms

Saquinavir mesylate BiologicalActivity

Description	Saquinavir mesylate is an HIV Protease Inhibitor used in antiretroviral therapy. IC50 Value:Target: HIV ProteaseSaquinavir is a protease inhibitor. Proteases are enzymes that cleave protein molecules into smaller fragments. HIV protease is vital for both viral replication within the cell and release of mature viral particles from an infected cell. Saquinavir binds to the active site of the viral protease and prevents cleavage of viral polyproteins, preventing maturation of the virus. Saquinavir inhibits both HIV-1 and HIV-2 proteases.Studies have also looked at Saquinavir as a possible anti-cancer agent.
Related Catalog	Signaling Pathways >>Autophagy >>AutophagySignaling Pathways >>Metabolic Enzyme/Protease >>HIV ProteaseSignaling Pathways >>Anti-infection >>HIVResearch Areas >>Infection
References	[1]. Kaldor et al (1995) Isophthalic acid derivatives: amino acid surrogates for the inhibition of HIV-1 protease. Bioorg.Med.Chem.Lett. 5 721. [2]. Yerino GA, Halabe EK, Zini E, Feleder EC.Bioequivalence study of two oral tablet formulations containing saquinavir mesylate boosted with ritonavir in healthy male subjects.Arzneimittelforschung. 2011;61(8):481-7. [3]. Branham ML, Moyo T, Govender T.Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement.Eur J Pharm Biopharm. 2012 Jan;80(1):194-202. [4]. Brouwers J, Vermeire K, Grammen C, Schols D, Augustijns P.Early identification of availability issues for poorly water-soluble microbicide candidates in biorelevant media: a case study with saquinavir.Antiviral Res. 2011 Aug;91(2):217-23. [5]. Knechten H, Lutz T, Pulik P, Martin T, Tappe A, Jaeger H.Safety and Efficacy in HIV-1-Infected Patients Treated with Ritonavir-Boosted Saquinavir Mesylate.

Description

Saquinavir mesylate is an HIV Protease Inhibitor used in antiretroviral therapy. IC50 Value:Target: HIV ProteaseSaquinavir is a protease inhibitor. Proteases are enzymes that cleave protein molecules into smaller fragments. HIV protease is vital for both viral replication within the cell and release of mature viral particles from an infected cell. Saquinavir binds to the active site of the viral protease and prevents cleavage of viral polyproteins, preventing maturation of the virus. Saquinavir inhibits both HIV-1 and HIV-2 proteases.Studies have also looked at Saquinavir as a possible anti-cancer agent.

Related Catalog

Signaling Pathways >>Autophagy >>AutophagySignaling Pathways >>Metabolic Enzyme/Protease >>HIV ProteaseSignaling Pathways >>Anti-infection >>HIVResearch Areas >>Infection

References

[1]. Kaldor et al (1995) Isophthalic acid derivatives: amino acid surrogates for the inhibition of HIV-1 protease. Bioorg.Med.Chem.Lett. 5 721.

[2]. Yerino GA, Halabe EK, Zini E, Feleder EC.Bioequivalence study of two oral tablet formulations containing saquinavir mesylate boosted with ritonavir in healthy male subjects.Arzneimittelforschung. 2011;61(8):481-7.

[3]. Branham ML, Moyo T, Govender T.Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement.Eur J Pharm Biopharm. 2012 Jan;80(1):194-202.

[4]. Brouwers J, Vermeire K, Grammen C, Schols D, Augustijns P.Early identification of availability issues for poorly water-soluble microbicide candidates in biorelevant media: a case study with saquinavir.Antiviral Res. 2011 Aug;91(2):217-23.

[5]. Knechten H, Lutz T, Pulik P, Martin T, Tappe A, Jaeger H.Safety and Efficacy in HIV-1-Infected Patients Treated with Ritonavir-Boosted Saquinavir Mesylate.

Chemical & Physical Properties

Boiling Point	1015ºC at 760 mmHg
Molecular Formula	C₃₉H₅₄N₆O₈S
Molecular Weight	766.946
Flash Point	567.7ºC
Exact Mass	766.372375
PSA	229.50000
LogP	5.48810
Vapour Pressure	0mmHg at 25°C
InChIKey	IRHXGOXEBNJUSN-YOXDLBRISA-N
SMILES	CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1.CS(=O)(=O)O
Storage condition	-20°C Freezer

Safety Information

RIDADR	NONH for all modes of transport

Articles27

Intranasal in situ gel loaded with saquinavir mesylate nanosized microemulsion: preparation, characterization, and in vivo evaluation.

Int. J. Pharm. 475(1-2) , 191-7, (2014)

Saquinavir mesylate (SM) is a protease inhibitor with activity against human immunodeficiency virus type 1 (HIV-1) and is available in tablet form, which has three major problems. First, the drug unde...

Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL.

Cell Cycle 11(6) , 1174-82, (2012)

We previously reported that the NO-modified form of HIV protease inhibitor Saquinavir (Saq) is a potent antitumoral agent efficient against numerous tumor cell lines in vitro and in vivo. In acute tox...

Can inhibition of proteasomes or NF-kappaB help control idiopathic nephrotic syndrome?

Nephrol. Dial. Transplant. 27(5) , 1698-701, (2012)

Synonyms

L-aspartamide, N-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-N-(2-quinolinylcarbonyl)-, methanesulfonate (1:1)

Saquinavir mesilate

acide méthanesulfonique - (2S)-N-{(1S,2R)-1-benzyl-3-[(3S,4aS,8aS)-3-[(1,1-diméthyléthyl)carbamoyl]octahydroisoquinoléin-2(1H)-yl]-2-hydroxypropyl}-2-[(quinoléin-2-ylcarbonyl)amino]butanediamide (1:1)

Saquinavir monomethanesulfonate salt

N-{(2S,3R)-3-Hydroxy-4-[(3S,4aS,8aS)-3-[(2-methyl-2-propanyl)carbamoyl]octahydro-2(1H)-isoquinolinyl]-1-phenyl-2-butanyl}-N-(2-quinolinylcarbonyl)-L-aspartamide methanesulfonate (1:1)

N-{(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-yl}-N-(quinolin-2-ylcarbonyl)-L-aspartamide methanesulfonate (1:1)

N-{(1S,2R)-1-benzyl-3-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl}-N-(quinolin-2-ylcarbonyl)-L-aspartamide methanesulfonate (salt)

(2S)-N-{(1S,2R)-1-benzyl-3-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl}-2-[(quinolin-2-ylcarbonyl)amino]butanediamide methanesulfonate (salt)

Methansulfonsäure--(2S)-N-{(1S,2R)-1-benzyl-3-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisochinolin-2(1H)-yl]-2-hydroxypropyl}-2-[(chinolin-2-ylcarbonyl)amino]butandiamid(1:1)

Saquinavir Mesylate

MFCD00944907

L-aspartamide, N-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-N-(2-quinolinylcarbonyl)-, methanesulfonate (1:1) (salt)

N1-{(1S,2R)-1-benzyl-3-[(3S,4aS,8aS)-3-[(tert-butylamino)carbonyl]octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl}-N2-(quinolin-2-ylcarbonyl)-L-aspartamide methanesulfonate (salt)

L-Aspartamide, N-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-N-(2-quinolinylcarbonyl)-, methanesulfonate (1:1) ; (salt)

Recommended......